Search All Lab Content

Our goal is to tackle difficult problems in human health and cancer biology. We work on the diseases of triple-negative breast cancer and other difficult-to-treat cancers.

The Gupta Lab employs modern approaches in molecular genetics and molecular/cellular biology to explore various aspects of adipocyte development.

We explore questions on genomes using a systems biology approach: developing and employing integrative approaches at the interface of gene regulation, epigenetics, single-cell genomics, and bioinformatics.

We are broadly interested in understanding how resident intestinal bacteria influence the biology of humans and other mammalian hosts.

We are multidisciplinary team of clinicians and scientists, focusing on liver cancer risk-predictive molecular biomarkers specific to clinical contexts (ex. geographic region, liver disease etiology, and patient race/ethnicity) individual risk-stratified personalized cancer screening.

 In diseases like cancer, signaling pathways can be corrupted by mutations that cause the cells to grow and spread uncontrollably. Our lab is interested in understanding how these defective pathways reprogram cellular metabolism to drive cancer growth.

The Jewell Lab investigates how organisms sense environmental nutrient fluctuations and respond appropriately, fine tuning anabolic and catabolic processes to control cell growth, metabolism, and autophagy.

We are broadly interested in understanding how resident intestinal microorganisms (particularly bacteria and fungi and collectively referred to as the gut microbiome) influence the health of human cancer and stem cell transplant patients.

We are taking a comparative genomics approach to identify genes that have been modified in the human brain.

We are interested in understanding how animals process both external and internal sensory information to interact appropriately with their environment.

Our mission is to improve the lives of people living with skin and musculoskeletal diseases through rigorous science and compassion.

We focus on

•  Therapeutic clinical trials in infectious diseases
•  Improving outcomes through the improvement of the delivery of health services
•  Analysis of outcomes among those with infections

The Parkland Outcomes after Prematurity Study research group focuses on the short- and long-term effects of preterm birth, to improve lifelong health outcomes for current and future patients.

The N-LAB's mission is to develop novel neuroimaging and neuroengineering methods to integrate molecular and system neuroscience and solve brain science problems.

Our mission is to understand the most fundamental questions in cancer biology, such as tumor initiation, progession, and response to therapy, through state-of-the-art experimentation, fruitful collaborations and, above all, out-of-the box thinking to develop novel, safe(r) and more effective therapies to win the fight against cancer!

The Liu Lab investigates genetic and environmental factors leading towards obesity and metabolic syndrome in children and adolescents.

The Ly Laboratory studies how cell cycle defects and mitotic errors shape the complex mutational landscape of human cancer genomes.

Using novel multi-omics approaches and model systems to treat pancreatic cancer

We study the molecular events that drive this process in a term pregnancy and how perturbation of these processes contribute to premature birth.

Our goal is to identify the metabolic mechanisms that push cells to become cancerous and find new ways to inhibit them.